iShares Neuroscience and Healthcare ETF (IBRN)

NYSEARCA: IBRN · Real-Time Price · USD

32.52

-0.32 (-0.98%)

Nov 2, 2026, 4:00 PM EST - Market closed

Assets	$6.66M
Expense Ratio	0.47%
PE Ratio	20.06
Forward PE	20.45
Shares Out	200,000
Dividend	$0.32 (0.98%)
Ex-Dividend Date	Dec 16, 2025
Payout Frequency	Annual
Payout Ratio	19.58%

Volume	2,404
Open	32.76
Previous Close	32.84
Day's Range	32.38 - 33.03
52-Week Low	27.70
52-Week High	43.01
Beta	0.67
Holdings	90
Inception Date	Aug 24, 2022

About IBRN

Fund Home Page

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care stocks. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is issued by BlackRock.

Asset Class Equity

Category Health

Region Global

Stock Exchange NYSE Arca

Ticker Symbol IBRN

ETF Provider BlackRock

Index Tracked NYSE FactSet Global Neuro Biopharma and MedTech Index

Top 10 Holdings

43.25% of assets

Name	Symbol	Weight
Biogen Inc.	BIIB	5.58%
Alkermes plc	ALKS	4.78%
Neurocrine Biosciences, Inc.	NBIX	4.57%
Edgewise Therapeutics, Inc.	EWTX	4.39%
PTC Therapeutics, Inc.	PTCT	4.22%
argenx SE	ARGX	4.21%
Axogen, Inc.	AXGN	3.97%
Praxis Precision Medicines, Inc.	PRAX	3.95%
Scholar Rock Holding Corporation	SRRK	3.86%
Dianthus Therapeutics, Inc.	DNTH	3.70%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 16, 2025	$0.31981	Dec 19, 2025
Dec 17, 2024	$0.10114	Dec 20, 2024
Dec 20, 2023	$0.0063	Dec 27, 2023
Jun 7, 2023	$0.00824	Jun 13, 2023

Full Dividend History

Performance

IBRN had a total return of 8.65% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.56%.